What we are studying
The purpose of this research study is to compare the safety and efficacy of toxin injections versus placebo for managing plantar fasciitis that has not responded to conservative treatment.
The study sponsor has developed a botulinum toxin product that has been named RT002 that has not been approved for this condition. RT002 is a botulinum toxin that has been studied for its use in cosmetics to treat wrinkles. The study performed showed no evidence of spread of the toxin through the body beyond the place where it was injected. Botulinum toxin has been studied in the treatment of plantar fasciitis, however, our study proposes adding an injection site with the hope that this will cause sustained rest of the inflamed plantar fascia in the same manner it causes sustained loss of wrinkles.
In this study RT002 will be compared to placebo. A placebo is a substance, like a sugar pill, that is not thought to have any effect on your disease or condition. In this study you will either receive the active study medication, RT002 or placebo which is not active. Placebos are used in research studies to see if the drug being studied really does have an effect.
$25 for completing 4 and 6 week visits, and $50 for completing the 16 week visit